Within Russian-Japanese business mission of the party discussed cooperation questions in area farmmedproma

@Minpromtorg Rossii
Show original

Today in Tokyo within business mission "Commerce and industry dialogue: Russia-Japan" took place "Cooperation in the Pharmaceutical and Medical Industry" session.

as a part of the Russian delegation Alexey Alyokhin (The deputy director of Development department of the pharmaceutical and medical industry of Minpromtorg of Russia), Sergey Yastrebov (The governor of the Yaroslavl region), Dmitry Morozov (The Director general of "BIOKAD"), Alexey Ordzhonikidze (The vice-president of R-Farm Group of companies, the Vice-president of Public organization "Business Russia"), Timur Andreyev (The director of Corporation of development of the Moscow region), Natalya Rabinovich (The Director general of Himrar Research institute), Anna Gorbatova (The deputy director general Tekhnopolisa "Moscow") took part.

From the Japanese party speakers acted Tikao Kamidzima (The vice-president, the Executive Director for marketing of Toshiba Medical Systems Corporation "Establishment of Russia-Japan Cardiac Imaging Training Centre", Akikhiro Taguti (the board member, the Senior Executive Director of Olympus Corporation "Endoscope Business in Russia"), Kenichi Komatsu (the Vice-president of Medical Excellence Japan), and also Andrey Potapov (The Director general across Russia and the CIS, Takeda Russia). A large number of Japanese participants of session, including representatives of profile association JPMA, testified to high interest from Japanese colleagues to prospects of development of the bilateral relations in pharmaceutical and medical branches.

Opening session, the moderator of action Alexey Ordzhonikidze noted that for the Russian companies important that they meet the interested response from the Japanese companies. Alexey Alyokhin told about measures of the state support of the pharmaceutical and medical industry in Russia and paid attention of foreign colleagues that Minpromtorg of Russia creates conditions under which it is more favorable to foreign companies to make goods in Russia.

the Role of the ministry were noted in the performance by Dmitry Morozov, having presented "success history" to the BIOKAD company which for the short period with support of the state could create and bring not simply to the market hi-tech medicines, but also started exporting made production surely.

the Russian side presented to Japanese colleagues various options of cooperation, having supported everyone with a practical case of development of interaction with foreign partners.

Representatives of the enterprises of the pharmaceutical and medical industry will continue the work in the B2B format during the second day of business mission.